## Abstract The activity of superoxide dismutases (SOD) I and 2 was analysed in correlation with mRNA and chromosome content in 6 SV40βtransformed (TF) and in nonβtransformed (NF) human fibroblast cell lines. Total SOD activity was fairly constant, whereas the ratio SOD2/SOD I was much lower in TF
Telomerase and telomere stability: A new class of tumor suppressor?
β Scribed by Lynne W. Elmore; Shawn E. Holt
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 75 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
β¦ Synopsis
Introduction of telomerase into normal cells provides telomere maintenance and an extended cellular life span, establishing the critical role of telomere attrition in cellular senescence. Additional data surrounding this observation suggest that expression of telomerase renders these "mortal" cells genomically stable with decreased frequencies of mutation, ultimately leading to continued proliferation without signs of changes typically associated with progression to a cancer-like phenotype. Interestingly, oncogenic insult after exogenous telomerase expression does not result in cellular transformation, yet addition of an oncogene first followed by telomerase does transform cells. Taken together, these results imply that order of addition is important for telomerase-mediated genomic protection and that telomerase expression is critical for the transformation process. The hypothesis proposed here is that telomerase, via its function in telomere stabilization, is capable of protecting cells from acquiring the required mutations and genomic instability necessary for malignant transformation, suggesting that telomerase is not an oncogene but may act as a novel class of tumor suppressor.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Ovarian cancer is characterized by complex genetic alterations, including copy number loss and copy numberβneutral loss of heterozygosity (LOH). These alterations are assumed to represent the βsecond hitβ of the underlying tumor suppressor gene (TSG), however, relative to the number of